Correlation Between Green Cross and Samsung Biologics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Green Cross and Samsung Biologics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Green Cross and Samsung Biologics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Green Cross Lab and Samsung Biologics Co, you can compare the effects of market volatilities on Green Cross and Samsung Biologics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Green Cross with a short position of Samsung Biologics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Green Cross and Samsung Biologics.

Diversification Opportunities for Green Cross and Samsung Biologics

0.61
  Correlation Coefficient

Poor diversification

The 3 months correlation between Green and Samsung is 0.61. Overlapping area represents the amount of risk that can be diversified away by holding Green Cross Lab and Samsung Biologics Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Samsung Biologics and Green Cross is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Green Cross Lab are associated (or correlated) with Samsung Biologics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Samsung Biologics has no effect on the direction of Green Cross i.e., Green Cross and Samsung Biologics go up and down completely randomly.

Pair Corralation between Green Cross and Samsung Biologics

Assuming the 90 days trading horizon Green Cross Lab is expected to under-perform the Samsung Biologics. In addition to that, Green Cross is 1.73 times more volatile than Samsung Biologics Co. It trades about -0.04 of its total potential returns per unit of risk. Samsung Biologics Co is currently generating about 0.02 per unit of volatility. If you would invest  83,300,000  in Samsung Biologics Co on August 25, 2024 and sell it today you would earn a total of  10,100,000  from holding Samsung Biologics Co or generate 12.12% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Green Cross Lab  vs.  Samsung Biologics Co

 Performance 
       Timeline  
Green Cross Lab 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Green Cross Lab has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
Samsung Biologics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Samsung Biologics Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Samsung Biologics is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Green Cross and Samsung Biologics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Green Cross and Samsung Biologics

The main advantage of trading using opposite Green Cross and Samsung Biologics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Green Cross position performs unexpectedly, Samsung Biologics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Samsung Biologics will offset losses from the drop in Samsung Biologics' long position.
The idea behind Green Cross Lab and Samsung Biologics Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.

Other Complementary Tools

Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Volatility Analysis
Get historical volatility and risk analysis based on latest market data